Profile of:

Mireia Moreno

Full name: Mireia Moreno

Current country: Spain

Membership level: Full

Type of membership: Member

Number of publications: 16

Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO (2022)

Sex-associated and gender-associated differences in the diagnosis and management of axial spondyloarthritis: addressing the unmet needs of female patients (2021)

Expert Consensus on a Set of Outcomes to Assess the Effectiveness of Biologic Treatment in Psoriatic Arthritis: The MERECES Study (2020)

Interobserver reliability of Masei index validation by a multicenter collaborative group of rheumatologists (2020)

Role of HLA-B27 in the comorbidities observed in Axial Spondyloarthritis: Data from COMOSPA (2020)

Ultrasound Assessment of Psoriatic Onychopathy: A Cross-sectional Study Comparing Psoriatic Onychopathy with Onychomycosis (2019)

Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study (2019)

Comparison of disease activity in patients with ankylosing spondylitis under TNFi or NSAID treatment, is there any difference? An observational study (2019)

Magnetic resonance imaging assessment in patients with axial spondyloarthritis: development of checklists for use in clinical practice (2019)

Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database (2018)

Should over-treatment of axial spondyloarthritis with biologics remain a concern after the issue of the new ASAS criteria? Data from REGISPONSERBIO (Spanish Register of Biological Therapy in Spondyloarthritides) (2018)

The EJES-3D tool for personalized prescription of exercise in axial spondyloarthritis through multimedia animations: pilot study (2018)

Recommendations of the Spanish Society of Rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritis (2018)

Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain (2017)

Etoricoxib in ankylosing spondylitis: is there a role for active patients refractory to traditional NSAIDs? (2016)

A report of 4 years of experience of a multidisciplinary unit of psoriasis and psoriatic arthritis (2014)